As of 2025-07-09, the EV/EBITDA ratio of Getein Biotech Inc (603387.SS) is 24.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 603387.SS's latest enterprise value is 4,345.82 mil CNY. 603387.SS's TTM EBITDA according to its financial statements is 181.09 mil CNY. Dividing these 2 quantities gives us the above 603387.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 25.9x - 29.4x | 28.0x |
| Forward P/E multiples | 10.4x - 19.3x | 14.7x |
| Fair Price | 8.80 - 17.37 | 11.33 |
| Upside | 8.5% - 114.2% | 39.7% |
| Date | EV/EBITDA |
| 2025-03-04 | 25.59 |
| 2025-03-03 | 25.20 |
| 2025-02-28 | 24.95 |
| 2025-02-27 | 25.40 |
| 2025-02-26 | 25.37 |
| 2025-02-25 | 25.23 |
| 2025-02-24 | 25.09 |
| 2025-02-21 | 25.20 |
| 2025-02-20 | 25.31 |
| 2025-02-19 | 25.15 |
| 2025-02-18 | 24.81 |
| 2025-02-17 | 25.48 |
| 2025-02-14 | 24.89 |
| 2025-02-13 | 24.22 |
| 2025-02-12 | 24.47 |
| 2025-02-11 | 24.53 |
| 2025-02-10 | 24.75 |
| 2025-02-07 | 24.36 |
| 2025-02-06 | 24.05 |
| 2025-02-05 | 23.52 |
| 2025-01-27 | 23.47 |
| 2025-01-24 | 23.38 |
| 2025-01-23 | 23.44 |
| 2025-01-22 | 23.35 |
| 2025-01-21 | 25.79 |
| 2025-01-20 | 24.39 |
| 2025-01-17 | 24.45 |
| 2025-01-16 | 24.36 |
| 2025-01-15 | 24.36 |
| 2025-01-14 | 23.83 |
| 2025-01-13 | 23.19 |
| 2025-01-10 | 23.72 |
| 2025-01-09 | 23.30 |
| 2025-01-08 | 23.33 |
| 2025-01-07 | 23.52 |
| 2025-01-06 | 23.58 |
| 2025-01-03 | 23.33 |
| 2025-01-02 | 23.77 |
| 2024-12-31 | 24.39 |
| 2024-12-30 | 25.01 |
| 2024-12-27 | 24.70 |
| 2024-12-26 | 24.39 |
| 2024-12-25 | 24.45 |
| 2024-12-24 | 24.67 |
| 2024-12-23 | 24.42 |
| 2024-12-20 | 25.31 |
| 2024-12-19 | 25.29 |
| 2024-12-18 | 25.37 |
| 2024-12-17 | 25.43 |
| 2024-12-16 | 26.46 |